Viewing Study NCT00806351


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-01-24 @ 6:26 AM
Study NCT ID: NCT00806351
Status: TERMINATED
Last Update Posted: 2012-12-20
First Post: 2008-11-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A8851021
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators